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INFECTIONS OF THE SURGICAL SITE may compro-mise the outcome of the operation and, un-
der certain circumstances, endanger the life of
the patient. Antisepsis of the surgical site and
of the surgeon’s hands is a mainstay of the pre-
vention of surgical site infection (SSI) through
conditions of asepsis, which is defined as per-
formance of a process or procedure under con-
ditions in which bacterial contamination has
been minimized.
The most common mode of transmission of
pathogens is via hands, and substantial evi-
dence exists that hand hygiene reduces the in-
cidence of infections [1]. The studies of Sem-
melweis and Holmes are the foundation of the
identification of handwashing as one of the
most important measures to be taken by health-
care practitioners to reduce cross-contamina-
tion. In 1847, Dr. Ignaz Semmelweis, a Vien-
nese physician, discovered that fatal infections
were spread among patients by physicians who
failed to wash their hands between examina-
tions [2]. Semmelweis instituted a disinfecting
procedure whereby physicians were required
to wash in a chloride of lime solution after au-
topsies and with soap and water between pa-
tient visits. Doctors also had to change into
clean coats before examining patients. As a re-
sult, hospital mortality rates from infectious
diseases declined.
Handwashing by clinical staff is the single
most important measure for preventing trans-
mission of nosocomial infection. Today, hand-
washing should be a simple, standard antisep-
tic technique. However, studies conducted at
hospitals worldwide have documented that
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ABSTRACT
Objective: To review the evidence regarding antisepsis and decolonization of the skin of the
patient and surgeon for the prevention of surgical site infection (SSI).
Data Sources: General bibliographic and specialist computer databases, along with manual
searching of reference lists of primary and review articles, were used to search for relevant
peer-reviewed citations.
Results: Antisepsis of the surgical site and of the hands of the surgeon is a mainstay in the
prevention of SSI. Waterless and scrubless alcohol-based products are an alternative to tra-
ditional antiseptic scrubs. Chlorhexidine-based products for skin preparation at the surgical
site have proved superior to other preparation products for bacterial decolonization. The ef-
ficacy of routine preoperative decolonization strategies, including the use of nasal mupirocin
ointment and antiseptic body washes, has not been established definitively by randomized
clinical trials.
Conclusions: Antisepsis of the skin of patient and surgeon are important in the prevention
of SSI. Preoperative decolonization strategies for prevention of SSI, particularly those caused
by antibiotic-resistant organisms, remain controversial.
Division of Acute Care Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan.
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compliance with handwashing is poor in the
healthcare setting.
Since the late 1800s, when Lister promoted
the application of carbolic acid to the hands 
of surgeons before procedures, preoperative
cleansing of the hands and forearms with an
antiseptic agent has been an accepted practice
[3,4]. In the next section, we review the evi-
dence regarding antisepsis and decolonization
of both patient and surgeon in efforts to pre-
vent SSI.
GUIDELINES FOR SURGEON 
HAND ANTISEPSIS
The Centers for Disease Control and Pre-
vention (CDC) Guideline for Handwashing
and Environmental Control was first published
in 1985 and provided basic recommendations
for hand hygiene [5]. The subsequent compre-
hensive CDC Guideline for Hand Hygiene in
Health-Care Settings, published in 2002, pro-
vides evidence-based recommendations of the
Healthcare Infection Control Practices Advi-
sory Committee (HICPAC) and the HIC-
PAC/Society of Healthcare Epidemiologists of
America (SHEA)/Association of Professionals
in Infection Control (APIC)/Infectious Dis-
eases Society of America (IDSA) Hand Hygiene
Task Force [1]. A section on “Surgical Hand
Antisepsis” was included, and the final rec-
ommendations are listed in Table 1.
The Guideline for the Prevention of Surgical
Site Infection [6], published in 1999, is an evi-
dence-based comprehensive summary issued
by the CDC and HICPAC. A summary and re-
view of these evidence-based guidelines was
also published, and summary recommenda-
tions for patient and surgeon antisepsis were
provided (Table 2) [7]. In 2002, the CDC
MMWR (Morbidity and Mortality Weekly 
Report) Guideline for Hand Hygiene in the
Healthcare Setting 10-25-2002 recommended
that “Surgical hand antisepsis using either an
antimicrobial soap (2–5 min scrub) or an alco-
hol-based handrub with persistent activity is
recommended before donning sterile gloves
when performing surgical procedures (Cate-
gory 1B recommendation).” The World Health
Organization (WHO) Guidelines on Hand Hy-
giene in Health Care (Advanced Draft) [8] was
published recently as part of the World Al-
liance for Patient Safety’s Global Patient Safety
Challenge 2005–2006 entitled “Clean Care is
Safer Care” and “Clean Hands are Safer
Hands.” This worldwide guideline reiterates
the CDC Hand Hygiene Guideline with regard
to surgical hand antisepsis.
ISSUES IN SURGICAL HAND 
HYGIENE AND ANTISEPSIS
Perioperative surgical hand hygiene is a
complex issue. The usual surgical antisepsis in-
volves scrubbing the skin with antiseptic solu-
tions. This procedure can damage the skin,
with a paradoxical subsequent higher risk of
infection for the patient. There now are several
efficient and quick-acting antiseptic alcohol so-
lutions that require no scrubbing. Because of
their efficacy, persistent effect, and skin pro-
tection, many experts have advised that classi-
TABLE 1. SURGICAL HAND ANTISEPSIS: RECOMMENDATIONS OF THE
U.S. CENTERS FOR DISEASE CONTROL AND PREVENTION
Remove rings, watches, and bracelets before beginning the surgical hand scrub (Category II).
Remove debris from underneath fingernails using a nail cleaner under running water (Category II).
Surgical hand antisepsis using either an antimicrobial soap or an alcohol-based hand rub with persistent activity
is recommended before donning sterile gloves when performing surgical procedures (Category IB).
When performing surgical hand antisepsis using an antimicrobial soap, scrub hands and forearms for the length
of time recommended by the manufacturer, usually 2–6 min. Long scrub times (e.g., 10 min) are not necessary
(Category IB).
When using an alcohol-based surgical hand-scrub product with persistent activity, follow the manufacturer’s
instructions. Before applying the alcohol solution, wash hands and forearms with a non-antimicrobial soap and
dry them completely. After application of the alcohol-based product as recommended, allow hands and
forearms to dry thoroughly before donning sterile gloves (Category IB)
From reference 4.
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TABLE 2. SUMMARY OF EVIDENCE-BASED GUIDELINES FOR PREVENTION OF
SSI FROM CENTERS FOR DISEASE CONTROL AND PREVENTION
Preparation of the patient
Category 1A Identify and treat all infections remote from the surgical site before elective operations; 
postpone operation until infection has resolved
Do not remove hair unless it is at or near the incision site and will interfere with surgery. 
If hair is removed, this should be done immediately beforehand, preferably with electric
clippers.
Category 1B Control the blood glucose concentration in all diabetic patients and avoid hyperglycemia 
perioperatively
Encourage abstinence from tobacco for a minimum of 30 days before surgery
Do not withhold indicated blood donations as a means to prevent SSI
Patients should shower or bathe with an antiseptic solution at least the night before surgery
Wash and clean the incision site to remove gross skin contamination prior to the antiseptic
skin preparation with an appropriate agent
Category 2 Prepare area by application of the antiseptic agent in concentric circles. The prepared area
should be large enough to accommodate any necessary drains or stomas.
Keep the preoperative hospital stay as short as possible consistent with adequate 
preparation for surgery
Hand/forearm antisepsis
Category 1B Keep nails short; do not wear artificial nails
Scrub the hands and forearms up to the elbows for at least 2 to 5 min with an 
appropriate antiseptic
After the scrub, keep hands and arms up and away from the body so that water runs from
the fingertips to the elbows. Dry with a sterile towel before donning sterile gown and
gloves
Category 2 Clean under each fingernail before the first scrub of the day
Unresolved: There is no recommendation regarding the wearing of nail polish
Infected/colonized surgical personnel
Category 1B Educate and encourage personnel with signs and symptoms of a transmissible infectious
disease to report it promptly to supervisors and occupational health officials
Develop and maintain policies regarding patient-care responsibilities when personnel have
potentially transmissible infections
Obtain cultures from and exclude from duty personnel with draining skin lesions until
infection is ruled out or the lesion has responded to anti-infective therapy
Do not routinely exclude from patient care those personnel colonized with organisms such
as Staphylococcus aureus or group A streptococci unless an epidemiologic link with
dissemination has been established
Antimicrobial prophylaxis
Category 1A Administer antibiotic prophylaxis only when indicated and only when efficacious against
the pathogens most commonly causing SSI for the particular operation
Administer initial dose intravenously, timed such that a bactericidal concentration of the
drug is present in the serum and tissues when the incision is made.
Maintain therapeutic concentrations of the agent in the serum and tissues for the duration
of the operation. Therapeutic levels should be maintained at most only until a few hours
after the incision is closed
Before elective colon operations, prepare the colon mechanically with enemas or cathartic 
agents. Administer nonabsorbable oral antimicrobial agents in multiple doses on the day
before surgery
For high-risk cesarian section, administer the prophylactic antibiotic agent immediately
after the umbilical cord is clamped
Category 1B Do not use vancomycin routinely for surgical prophylaxis
Surgical attire and drapes
Category 1B Wear surgical mask to cover the mouth and nose fully for the duration of the operation or
while sterile instruments are exposed*
Wear a cap or hood so as to cover all hair on head and face fully*
Wear sterile gloves after a sterile gown is donned (all scrubbed surgical team members)*
Do not wear shoe covers for the prevention of SSI*
The surgical gowns and drapes used should be effective barriers when wet




cal scrubbing with antiseptic solutions be re-
placed with gentle washing with a waterless al-
cohol solution [9].
The introduction of waterless, scrubless al-
cohol-based hand antiseptics into the operating
room, where traditional scrubbing has been the
standard, requires education for proper appli-
cation and initiation of programs to monitor
methodology and compliance. The integration
of these rinseless products has been challeng-
ing. Contributing to the confusion is the U.S.
Food and Drug Administration (FDA) state-
ment that products considered to be surgical
scrubs must show characteristics that include
immediate microbial killing, broad-spectrum
activity, and persistence of the effect for as long
as six hours.
One of the largest surgical antisepsis studies
compared hand rubbing with aqueous alcohol
(75% aqueous alcoholic solution containing
propanol-1, propanol-2, and mecetronium etil-
sulfate) with traditional scrubbing with an an-
tiseptic preparation containing 4% povidone-
iodine or 4% chlorhexidine gluconate. A total
of 4,387 consecutive patients who underwent
clean and clean-contaminated surgery were
studied in a randomized equivalence trial [10].
The 30-day SSI rates were 55 of 2,252 (2.44%)
with the hand-rubbing protocol and 53 of 2,135
(2.48%) with the hand-scrubbing protocol, for
a difference of 0.04% (95% confidence interval,
-0.88%, 0.96%) (Table 3). Compliance with the
recommended duration of hand antisepsis was
better in the hand-rubbing than the hand-
scrubbing protocol (44% vs. 28%, respectively;
p  0.008), as was tolerance, with less skin dry-
ness and irritation after aqueous alcohol use.
Hand rubbing with aqueous alcoholic solution,
preceded by a 1-min nonantiseptic hand wash
before each surgeon’s first procedure of the day
and before any procedure if the hands were
soiled, was as effective as traditional hand
scrubbing in preventing SSIs. The hand-rub-
bing protocol was tolerated better by the sur-
gical teams and improved compliance with hy-
giene guidelines, leading to the conclusion that
Unresolved No recommendations are made about restricting scrub suits to the operating suite or
covering them when out of the suite
Asepsis and surgical technique
Category 1A Adhere to principles of asepsis when placing intravascular devices or when dispensing or
administering intravenous drugs
Category 1B Handle tissue gently, maintain hemostasis, minimize devitalized or charred tissue and
foreign bodies, and eradicate dead space at the surgical site
Use delayed primary skin closure or allow incisions to heal by secondary intention if the
surgical site is contaminated or dirty
Use closed suction drains when drainage is necessary, placing the drain through a separate
incision distant from the operative incision. Remove drains as soon as possible
Category 2 Assemble sterile equipment and solutions immediately prior to use
Postoperative incision care
Category 2 Keep a sterile dressing for 24 to 48 h postoperatively on an incision closed primarily. 
No recommendation is made regarding keeping a dressing on the wound beyond 48 h or
for bathing and showering after the bandage is removed
Wash hands before and after changing dressings and any contact with the surgical site. Use
sterile technique to change dressings
Educate the patient about SSI, relevant symptoms and signs, and the need to report them if
noted
Unresolved No recommendation is made with respect to keeping an incision covered for more than
48 h
*Regulated by the U.S. Occupational Health and Safety Administration.
Recommendations for intraoperative ventilation, cleaning and disinfection of environmental surfaces, sterilization of
surgical instruments, epidemiologic investigations in the operating room, and surveillance may be found in the source
document.
SSI  surgical site infection.
Modified from reference 1.
TABLE 2. SUMMARY OF EVIDENCE-BASED GUIDELINES FOR PREVENTION OF
SSI FROM CENTERS FOR DISEASE CONTROL AND PREVENTION (CONT’D)
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hand rubbing with a liquid aqueous alcoholic
solution can be used safely for preoperative
hand hygiene.
In another study [11], a comparison of five
protocols for surgical handwashing confirmed
that the alcohol-based antiseptics were associ-
ated with significantly lower numbers of
colony-forming units in two of the three post-
scrub samples (p  0.003, p  0.035). The five
study protocols were: (1) An initial scrub of 5
min and consecutive scrubs of 3.5 min with 4%
chlorhexidine gluconate; (2) an initial scrub of
3 min and consecutive scrubs of 2.5 min with
4% chlorhexidine gluconate; (3) an initial scrub
of 3 min and consecutive scrubs of 2.5 min with
5% povidone-iodine and 1% triclosan; (4) an
initial scrub of 2 min with 4% chlorhexidine
gluconate followed by a 30 sec application of
70% isopropyl alcohol and 0.5% chlorhexidine
gluconate, and a 30 sec application of 70% iso-
propyl alcohol and 0.5% chlorhexidine glu-
conate for consecutive scrubs; (5) an initial
scrub of 2 min with 4% chlorhexidine gluconate
followed by a 30 sec application of 70% ethanol
and 0.5% chlorhexidine gluconate, and a 30 sec
application of 70% ethanol and 0.5% chlorhex-
idine gluconate for consecutive scrubs. A scrub
protocol using alcohol-based antiseptics was as
effective as and no more damaging to skin than
more time-consuming conventional methods
using detergent-based antiseptics.
Similarly, Kac et al. [12] found that hand rub-
bing with an alcohol-based solution produced
a significantly greater reduction in microbio-
logical load than handwashing with unmed-
icated soap (p  0.0001 for palms and p 
0.0003 for fingertips). After hand rubbing, no
transient pathogens were recovered, whereas
pathogens were recovered after handwashing
in two cases. This study also confirmed that
rubbing was more efficacious than washing for
the decontamination of healthcare workers’
hands after contact with patients and patient
environments [12]. Handrubbing with an alco-
hol-based solution also is significantly more ef-
ficient in reducing hand contamination than
washing with an antiseptic soap [13,14]. Fur-
thermore, it has been recognized that an alco-
hol-based hand antiseptic used in conjunction
with a scrub agent (i.e., after a brief surgical
scrub) enhances the effectiveness of decontam-
ination [15].
Additional studies have documented that
hand antisepsis with an alcoholic gel regimen
is well tolerated and does not cause skin irri-
tation and dryness. In contrast, skin irritation
and dryness increased significantly when
washing with the unmedicated soap product.
Newer alcoholic hand gels that are less irritat-
ing than soap may be more acceptable to staff
and lead to better hand-hygiene practices
[16,17].
Chlorhexidine gluconate and alcohol gel as
disinfectants were compared in a randomized
trial involving orthopedic surgeons [18]. The
hand-washing protocol dictated that all sur-
geons wash for 5 min with chlorhexidine be-
fore their first case. Thereafter, the surgeon was
randomized to wash for 3 min with either al-
cohol gel or chlorhexidine. At the end of each
procedure, the gloves were removed, and an
impression of the surgeon’s fingertips was
made on an agar plate. The numbers of bacte-
rial colonies present after 24 h and 48 h of in-
cubation were recorded for each agar plate by
a microbiologist unaware of the washing pro-
tocol. Overall, 41 procedures and 82 episodes
of hand washing were studied. Four hands
(8%) were contaminated in the chlorhexidine
group compared with 19 (34%) in the alcohol
TABLE 3. SURGICAL SITE INFECTON (SSI) RATES AND DIFFERENCES BETWEEN HAND SCRUBBING AND HAND RUBBING
Percent
Altemeier class difference in SSI 2 test of
of rate, scrubbing vs. equivalence
contamination Hand scrubbing Hand rubbing rubbing (95% CI) (p value)
Clean 29/1,485 (1.95) 32/1,520 (2.11) 0.15 (1.16, 0.85) 16.0 (0.001)
Clean-contaminated 24/650 0 (3.69) 23/732 0 (3.14) 0.55 (1.36, 2.46) 1.9 0 (0.09)
All 53/2,135 (2.48) 55/2,252 (2.44) 0.04 (0.88, 0.96) 19.5 (0.001)
CI  confidence interval.
From reference 10.
No. SSI/no. operations (%)
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group (p  0.002; Fisher exact test). In addition,
the average colony count was substantially
higher in the alcohol group (20 colony forming
units [CFU]) than in the chlorhexidine group (5
CFU). However, this is the only study to iden-
tify a higher risk of bacterial contamination of
surgeons’ hands washed with alcohol.
A comparison of the agents currently avail-
able for surgical hand antisepsis is presented in
Table 4. A working knowledge of the charac-






















may be ototoxic and
cause corneal damage
Not for use past superficial
layers of skin
Less irritating than many
agents; allergic reactions
uncommon
Molecular iodine in carrier
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more contact dermatitis
than other antiseptics















































Fair activity against M.
tuberculosis, some fungi,
certain viruses
Less persistent than CHG
Minimally affected by
organic matter
Surgical hand scrubs and
rubs; less for preparation
Not recommended when




Used for hand antisepsis in
high-risk areas such as
ED and ICU
Used for skin preparation
Activity reduced by anionic
surfactants in many hand
lotions
Influenza and RSV
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teristics, efficacy, and appropriate indications
of these products is necessary for all practicing
surgeons. The microbiologic activities and po-
tential uses of these antiseptics are provided in
detail in Table 5.
An alcohol-based product that could be used
to decontaminate the hands with or without
water (i.e., water optional) while providing im-
mediacy of killing and persistence could re-
duce the confusion associated with the national
handwashing guidelines [19]. Such a product
has been developed. Triseptin (Healthpoint,
Inc., Fort Worth, TX), which is alcohol-based
(61%) and zinc pyrithione (ZPT)-preserved, is
compliant with the FDA and CDC guidelines.
The 61% alcohol-ZPT product easily produced
3.0 log10 reductions in the indicator strain
(Serratia marcescens) with the first wash, ex-
ceeding the 2.0 log10 FDA requirement. This
level of performance was maintained through
the tenth wash, surpassing the 3.0 log10 FDA
requirement for the handwash indication. For
the assessment of persistence and residual ef-
fect in the waterless mode, the water-optional,
61% alcohol-ZPT product consistently pro-
duced log10 reductions of 3.5 or greater at every
point over the entire study period. In the wa-
ter-aided configuration, similar results were
obtained, as log10 reductions of 2.5 were ob-
served. The formulation was non-irritating, ac-
tually improving hand skin condition. The 61%
alcohol-ZPT product therefore exceeded all
FDA criteria for the health care personnel
handwash indication and is a substantial ad-
vancement in the concept of skin antisepsis in
that it is a single product suitable for all hand-
hygiene settings and demonstrates better an-
timicrobial persistence and residual effects. A
previously reported study has documented it
to be virucidal for several DNA and RNA
viruses [20].
PREOPERATIVE BATHING OR
SHOWERING WITH SKIN 
ANTISEPTICS TO PREVENT SSI
Preoperative bathing or showering with an
antiseptic skin wash product is a well-ac-
cepted and commonly recommended proce-
dure for reducing skin bacteria and mi-
croflora prior to surgery. The CDC Guideline
for the Prevention of Surgical Site Infection
now “strongly recommends” (Category IB)
that healthcare facilities “require patients to
shower or bathe with an antiseptic agent on
at least the night before the operative day,”
as a preoperative antiseptic shower or bath
decreased skin microbial colony counts nine-
fold in the studies they cite. Although the
CDC cautions that the showers have not been
shown definitively to reduce SSI rates, the
practice is sound as it relates to skin microbi-
ology, given the fact that the majority of SSIs
are associated with skin flora.
A recent Cochrane systematic review exam-
ined six trials of preoperative bathing involv-
ing a total of 10,007 participants [21]. The anti-
septic used in all trials was 4% chlorhexidine
gluconate. Bathing with chlorhexidine com-
TABLE 4. CHARACTERISTICS, EFFICACY, AND INDICATIONS FOR VARIOUS CLASSES OF TOPICAL SKIN ANTISEPTICS (CONT’D)
Characteristics Efficacy Indications
Abbreviations: RSV  respiratory syncytial virus; HBV  hepatitis B virus; HCV  hepatitis C virus; HIV  human
immunodeficiency virus; CMV  cytomegalovirus; ED  emergency department; ICU  intensive care unit; FDA 
U.S. Food and Drug Administration.
Ideal concentration not
known; 1%–2%



















In 1994, FDA Tentative
Final Monograph stated
“Triclosan less than 1
percent: insufficient data
exists to classify this
agent as safe and








pared with a placebo did not result in a statis-
tically significant reduction in SSIs (relative risk
[RR] 0.91; 95% confidence interval [CI] 0.80,
1.04). When only high-quality trials were ana-
lyzed, the results were no different (RR 0.95;
95% CI 0.82, 1.0). Three trials of 1,443 partici-
pants compared bar soap with chlorhexidine;
there was no difference in the risk of SSIs (RR
1.02; 95% CI 0.57, 1.84). Two trials involv-
ing 1,092 patients compared bathing with
chlorhexidine and no washing; likewise, no dif-
ference was found (RR 0.70; 95% CI 0.19, 2.58).
This Cochrane review provides evidence of no
benefit for preoperative showering or bathing
with chlorhexidine over other wash products.
Efforts to reduce the incidence of nosocomial
SSI should focus on interventions where effect
has been demonstrated.
ANTISEPSIS OF THE SURGICAL SITE
Antiseptic preoperative skin site cleansing is
used to prepare the operative site before mak-
ing a surgical incision. The goal is a reduction
in postoperative SSI. The usual method is
scrubbing the skin with an antiseptic, tradi-
tionally povidone-iodine solution. Just as with
surgeon hand hygiene, this procedure can
damage the skin, possibly increasing the risk of
infection. There are several efficient and quick-
acting antiseptic alcohol solutions that require
TABLE 5. MICROBIOLOGIC ACTIVITIES AND POTENTIAL USES OF ANTISEPTICS
Potential uses
Speed Effect of
of organic Surgical Skin
Group Gram Gram TB Viruses Fungi Endospores action matter scrub prep. Comments




















Povidone- Exc Exc Fair Good Good None Int Mod Yes Yes Can be used
iodine on mucous
(7.5–10%) membranes




Triclosan Exc Good Fair Exc None Unknown Int Minimal Yes No Acceptability
(0.2–2%) on hands
varies
a60–90% ethyl or isopropyl.
Abbreviations: TB  Mycobacterium tuberculosis; Exc  excellent; Mod  moderate; Int  intermediate; PCMX  para-
chlorometaxylenol.
Adapted from reference 1 and Olmsted RN, ed. Infection control and applied epidemiology: principles and practices.
St. Louis, MO: CV Mosby, 1996: table 19-2.
Spectrum of activity
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no scrubbing. The traditional preoperative
practice is increasingly being replaced by
chlorhexidine, which, unlike povidone-iodine,
remains active in the presence of blood and
serum. One application of chlorhexidine ex-
ceeds the FDA criteria for antisepsis in preop-
erative patient skin preparation. ChloraPrep
(2% chlorhexidine gluconate and 70% iso-
propyl alcohol; Medi-Flex, Inc., Leawood, KS)
was superior to DuraPrep (0.7% iodine and
74% isopropyl alcohol; 3M Corp., St. Paul, MN)
and Techni-Care (3.0% chloroxylenol; Care-
Tech Laboratories, St. Louis, MO) in eliminat-
ing bacteria in a prospective study of 125 con-
secutive patients undergoing surgery of the
foot and ankle [22]. These findings were con-
firmed in a randomized study [23].
It is crucially important to educate healthcare
practitioners in the proper method of applica-
tion of chlorhexidine solution, which should be
scrubbed on for 30 sec in a back-and-forth mo-
tion, the friction of which is part of what makes
the solution effective. The area does not need
be doused or flooded with this agent, as some
do with povidone-iodine solution. Scrubbing it
on to cover the intended area is sufficient. The
prepared area must then be allowed to dry
completely, and the solution should not be
blotted or wiped away. The preparation con-
tains alcohol; therefore, adequate drying is also
important for the prevention of fires caused by
electrocautery. One previous difficulty with
chlorhexidine skin preparations was the in-
ability to discern that all areas of the skin had
been covered, because the solution was color-
less. A teal-colored tint has now been added for
easier visibility.
If povidone-iodine skin preparation is to be
used, there is still the question of whether scrub-
and-paint vs. paint alone is superior. A ran-
domized trial in 240 patients undergoing non-
laparoscopic abdominal operations compared a
vigorous 5-minute scrub with povidone-iodine
soap followed by absorption with a sterile towel
and painting with aqueous povidone-iodine
(n  115) with site preparation with povidone-
iodine paint only (n  119) [24]. The primary
endpoint was the 30-day SSI rate, defined as the
presence of clinical signs of infection necessitat-
ing therapeutic intervention. The patients in the
two groups were well matched with respect to
age, co-morbidity, wound classification, mean
operative time, placement of drains, prophylac-
tic antibiotic use, and surgical procedure (all p 
0.09). Surgical site infection occurred in 12 (10%)
scrub-and-paint patients and 12 (10%) paint-
only patients. According to the predefined pa-
rameters, these results were equivalent, sug-
gesting that preoperative preparation of the
abdomen with a povidone-iodine soap scrub
and painting with aqueous povidone-iodine can
be abandoned in favor of painting alone. How-
ever, this trial had a small sample size, and val-
idation of the findings is warranted.
SKIN ANTISEPSIS IN CLEAN SURGERY
It is unclear whether preoperative skin anti-
sepsis actually reduces SSI in clean surgery. A
Cochrane review that examined this issue con-
cluded that there is insufficient evidence that
cleaning patients’ skin with antiseptic before
clean surgery reduces SSI [25]. Six eligible ran-
domized controlled trials evaluated antiseptics
applied immediately prior to incision in clean
surgery. There was significant heterogeneity in
the design of studies, however, and the results
could not be pooled. In one of these studies, in-
fection rates were significantly lower when
skin was prepared using chlorhexidine rather
than iodine. There was no evidence of a bene-
fit in four trials that examined the use of
iodophor-impregnated drapes.
A recent prospective cohort study compared
SSI rates of 905 control patients who underwent
skin preparation with normal saline compared
with 905 patients for whom either chlorhexidine
or povidone-iodine skin preparation was used.
In both patient groups, a preoperative shower of
the surgical site with soap and water was re-




Staphylococcus aureus remains the most com-
mon cause of SSI. The ecologic niche of S. 
aureus is the anterior nares, and nasal colo-
nization by the organism is common. Approx-
imately one-third of humans have skin and mu-
cosal colonization by S. aureus, although most
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never become ill as a result. However, carriers
are at higher risk for staphylococcal infections
after invasive medical or surgical procedures
than are non-carriers [27,28].
Decolonization, the use of antibiotics or an-
tiseptics to reduce the magnitude of the reser-
voir in colonized patients, may be a useful un-
dertaking. Several studies have reported lower
rates of SSI among colonized patients who re-
ceived 2% mupirocin ointment to the nares
than among historical control subjects [29–31],
although there is no benefit to the use of
mupirocin for non-colonized patients.
A large randomized, double-blind, placebo-
controlled trial (the Mupirocin and the Risk of
Staphylococcus aureus — MARS — Study) exam-
ined whether preoperative nasal decolonization
with mupirocin would decrease the rate of S. au-
reus SSI [32]. Overall, 2.3% of mupirocin recipi-
ents and 2.4% of the placebo recipients had S.
aureus SSIs among the 3,864 patients in the in-
tent-to-treat analysis, who underwent general,
gynecologic, neurologic, or cardiothoracic sur-
gery. Thus, prophylactic intranasal application
of mupirocin did not significantly reduce the
rate of S. aureus SSIs [32]. Interestingly, it did de-
crease significantly the rate of all nosocomial S.
aureus infections among the patients who were
carriers (4.0% vs. 7.7%; odds ratio [OR] 0.49; 95%
CI, 0.25, 0.92; p  0.002).
Another randomized study in 395 digestive
surgery patients compared intranasal mupirocin
30 mg TID preoperatively for three days with no
drug [33]. There were 21 gram-positive SSIs, 10
in the treated group and 11 in the control pa-
tients. Thus, intranasal mupirocin treatment had
no significant impact on SSI after digestive
surgery. However, this study did identify a sig-
nificant reduction in the incidence of postopera-
tive pneumonia, with none in the mupirocin-
treated group and five in control patients (p 
0.028), with MRSA being the causative pathogen
in four of the latter five patients.
DECOLONIZATION OF 
COLONIZED PATIENTS
A number of surgical patients are colonized
with antibiotic-resistant pathogens, particu-
larly methicillin-resistant S. aureus (MRSA), in
the preoperative period and therefore are at
higher risk for SSI with these pathogens. Con-
sensus regarding the optimal preoperative
preparation of MRSA-colonized patients, and
whether preoperative decolonization should 
be attempted, has not been achieved. Further-
more, the optimal antimicrobial or antiseptic
agents to use for prophylaxis in these colonized
patients have not been determined.
A number of studies have documented a re-
duction in SSI with decolonization, but most
were not randomized and controlled [30,34,35].
Topical perioperative prophylaxis for preven-
tion of MRSA SSIs was examined using a 
controlled before–after approach on patients
undergoing insertion of metal orthopedic pros-
theses or fixation. Patients received periopera-
tive prophylaxis with nasal mupirocin oint-
ment for five days and a shower or bath with
2% triclosan before surgery. Patients were fol-
lowed for 12 months postoperatively. After in-
troduction of the decolonization regimen, there
was a marked decrease in the incidence of
MRSA SSIs, from 23 per 1000 operations in the
six months before the regimen to 3.3 (p  0.001)
and 4 (p  0.001) in subsequent consecutive
six-month periods. Point prevalence nasal car-
riage of MRSA decreased from 38% before the
decolonization regimen was initiated to 23%
immediately after, and 20%, 7%, 10%, and 8%
(p  0.001) at six-monthly intervals post-inter-
vention [36]. Low-level mupirocin resistance
was identified in 2.3% of S. aureus isolates from
patients before the decolonization regimen was
initiated and in 3.9%, 6.1%, 10%, and 0% in sub-
sequent six-month periods. Furthermore, no 
S. aureus strains with high-level mupirocin re-
sistance were isolated. The study investigators
concluded that this regimen could reduce the in-
cidence of MRSA SSI after orthopedic surgery,
probably by reducing endemic nasal MRSA car-
riage, without selecting for mupirocin resistance.
On the other hand, a randomized, placebo-con-
trolled, double-blind trial to evaluate the efficacy
of mupirocin for eradicating carriage of MRSA
suggested that nasal mupirocin was only mar-
ginally effective in the eradication of multi-site
MRSA carriage in a setting where MRSA was en-
demic [37]. The SHEA Guideline for Preventing
Nosocomial Transmission of Multidrug-Resis-
tant Strains of Staphylococcus aureus and Entero-
coccus (May 2003) can be found in Table 6
[38–47]. Similarly, the Guidelines for the Con-
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trol and Prevention of MRSA in Healthcare Fa-
cilities, published by the Joint Working Party of
the British Society of Antimicrobial Chemother-
apy, the Hospital Infection Society, and the In-
fection Control Nurses Association [48] recently
published recommendations regarding decolo-
nization (Table 7).
A Cochrane review examined all randomized,
controlled trials of MRSA-colonized patients who
were decolonized with topical or systemic an-
timicrobials or given a placebo or no treatment,
as well as trials that compared combinations of
single topical or systemic agents with no treat-
ment, placebo, or topical or systemic agents [49].
Six trials (384 participants) met the inclusion cri-
teria. No difference in MRSA eradication was 
detected in four studies: One that compared
mupirocin with placebo, two that compared one
systemic agent with no treatment (fusidic acid in
one and rifampin or minocycline in the other),
and one that compared mupirocin with topical
fusidic acid and oral trimethoprim–sulfame-thox-
azole. One study compared minocycline with ri-
fampin, with rifampin being more effective in the
eradication of MRSA from all sites at day 30 (RR
0.16; 95% CI 0.02, 1.00), but there was no differ-
ence at 90 days. Two studies (one testing novo-
biocin and rifampin, the other cipro-floxacin and
rifampin, versus trimethoprim–sulfamethoxa-
zole and rifampin) demonstrated no difference in
eradication of MRSA at all sites (n  94). Adverse
events occurred in as many as 20% of participants
receiving systemic agents; however, event re-
porting was sporadic, and denominators were
small. All trials detected development of resis-
tance to antimicrobial agents used. The conclu-
sion is that there is insufficient evidence to sup-
port use of topical or systemic antimicrobials for
eradicating nasal or extra-nasal MRSA, and there
is no demonstrated superiority of either topical
or systemic therapy, or of combinations of these
agents, yet potentially serious adverse events and
antimicrobial resistance can result.
Another guideline, the North Carolina Guide-
lines for Control of Antibiotic-Resistant Organ-
isms [50], states: “Routine decolonization for
MRSA is not recommended. The need for de-
colonization should be based on the patient’s
medical condition and expected outcome. Topi-
TABLE 7. JOINT BRITISH GUIDELINES FOR CONTROL AND
PREVENTION OF MRSA IN HEALTHCARE FACILITIES
Nasal decolonization
Patients receiving prophylaxis for an operative
procedure and in an outbreak situation under the
advice of the infection control team should undergo
nasal decolonization. This should be undertaken by
applying mupirocin 2% in a paraffin base (ointment)
to the inner surface of each nostril (anterior nares)
three times daily for five days. The patient should be
able to taste mupirocin at the back of the throat after
application (Category 1B).
Mupirocin should not be used for prolonged periods or
used repeatedly (i.e., for more than two courses for
five days), as resistance may be encouraged
(Category 1A). The presence of a foreign body such
as a nasogastric tube may reduce the efficacy of
treatment with nasal mupirocin (Category 2).
Nasal decolonization using topical nasal mupirocin
should be used with other forms of intervention such
as skin decolonization with 4% chlorhexidine
gluconate aqueous solution (Category 2).
Skin decolonization
Skin decolonization using 4% chlorhexidine
bodywash/shampoo, 7.5% povidone-iodine or 2%
triclosan is useful in eradicating or suppressing skin
colonization for short times, particularly pre-
operatively to reduce the risk of SSIs (Category 1A).
Patients should bathe daily for five days with the
chosen antiseptic detergent. The skin should be
moistened and the antiseptic detergent should be
applied thoroughly to all areas before rinsing in the
bath or shower. Special attention should be paid to
known carriage sites such as the axilla, groin and
perineal area. The antiseptic should also be used for
all other washing procedures and for bed bathing.
Hair should be washed with antiseptic detergent
(Category 1A).
After satisfactory completion of a course of treatment,
clean clothing, bedding and towels should be
provided after each bath and hairwash (Category 2).
MRSA  methicillin-resistant Staphylococcus aureus.
TABLE 6. SHEA GUIDELINE FOR PREVENTING
NOSOCOMIAL TRANSMISSION OF MULTIDRUG-RESISTANT
STRAINS OF GRAM-POSITIVE COCCI
Consider MRSA decolonization therapy for both
patients and healthcare workers as an adjunctive
measure for controlling spread of MRSA in selected
populations when appropriate (Category IB)
Any program of decolonization therapy should
incorporate routine susceptibility testing, as selection
of inactive agents is less likely to achieve eradication
(Category II)
Widespread use, prolonged use, or both of
decolonization therapy should be avoided, because
this has been associated with the evolution and
spread of antibiotic-resistant strains, undermining the
effectiveness of the control effort (Category IB)
SHEA  Society of Healthcare Epidemiologists of
America; MRSA  methicillin-resistant Staphylococcus 
aureus.
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cal or systemic antibiotics, including trimetho-
prim–sulfamethoxazole, rifampin, ciprofloxacin,
erythromycin, doxycycline, bacitracin, and
mupirocin have been used with variable results
to eradicate colonization by MRSA. Vancomycin
is not indicated for decolonization therapy, as it
is ineffective for this purpose. There is no clini-
cally proven decolonization regimen for van-
comycin-resistant enterococci (VRE).”
REFERENCES
1. Boyce JM, Pittet D; Healthcare Infection Control Prac-
tices Advisory Committee, HICPAC/SHEA/APIC/
IDSA Hand Hygiene Task Force. Guideline for Hand
Hygiene in Healthcare Settings. MMWR 2002;51(RR-
16):1–48.
2. Wyklicky H, Skopec M. Ignaz Philipp Semmelweis,
the prophet of bacteriology. Infect Control 1983;4:
367–370.
3. Classic articles in colonic and rectal surgery. On the an-
tiseptic principle in the practice of surgery by Joseph
Lister 1867. Dis Colon Rectum 1982;25:173–178.
4. Gröschel DHM, Pruett TL. Surgical antisepsis. In:
Block SS, ed. Disinfection, sterilization and preserva-
tion. 4th ed. Philadelphia. Lea and Febiger, 1991.
5. Garner JS, Favero MS. CDC Guideline for hand-
washing and hospital environmental control, 1985. In-
fect Control 1986;7:231–243.
6. Mangram AJ, Horan TC, Pearson ML, et al. Guideline
for prevention of surgical site infection, 1999. Hospi-
tal Infection Control Practices Advisory Committee.
Infect Control Hosp Epidemiol 1999;20:250–278.
7. Lee JT. A new surgical site infection (SSI) prevention
guideline. Surgical Infections 2000;1:127–131.
8. Available at http://www.who.int/patientsafety/
events/05/HH_en.pdf.
9. Herruzo-Cabrera R, Vizcaino-Alcaide MJ, Fernandez-
Acenero MJ. Usefulness of an alcohol solution of N-
duopropenide for the surgical antisepsis of the hands
compared with handwashing with iodine-povidone
and chlorhexidine: Clinical essay. J Surg Res 2000;
94:6–12.
10. Parienti JJ, Thibon P, Heller R, Antisepsie Chirurgi-
cale des Mains Study Group. Hand-rubbing with an
aqueous alcoholic solution vs. traditional surgical
hand-scrubbing and 30-day surgical site infection
rates: A randomized equivalence study. JAMA
2002;288:722–727.
11. Pereira LJ, Lee GM, Wade KJ. An evaluation of five
protocols for surgical handwashing in relation to skin
condition and microbial counts. J Hosp Infect 1997;36:
49–65.
12. Kac G, Podglajen I, Gueneret M, et al. Microbiological
evaluation of two hand hygiene procedures achieved
by healthcare workers during routine patient care: A
randomized study. J Hosp Infect 2005;60:32–39.
13. Girou E, Loyeau S, Legrand P, et al. Efficacy of han-
drubbing with alcohol based solution versus standard
handwashing with antiseptic soap: Randomised clin-
ical trial. BMJ 2002;325:362–364.
14. Mulberry G, Snyder AT, Heilman J, et al. Evaluation
of a waterless, scrubless chlorhexidine gluconate/
ethanol surgical scrub for antimicrobial efficacy. Am
J Infect Control 2001;29:377–382.
15. Nishimura C. Comparison of the antimicrobial effi-
cacy of povidone-iodine, povidone-iodine-ethanol
and chlorhexidine gluconate–ethanol surgical scrubs.
Dermatology 2006;212(Suppl 1):21–25.
16. Boyce JM, Kelliher S, Vallande N. Skin irritation and
dryness associated with two hand-hygiene regimens:
Soap-and-water hand washing versus hand antisep-
sis with an alcoholic hand gel. Infect Control Hosp
Epidemiol 2000;21:442–448.
17. Larson EL, Aiello AE, Heilman JM, et al. Comparison
of different regimens for surgical hand preparation.
AORN J 2001;73:412–414, 417–418, 420.
18. Hajipour L, Longstaff L, Cleeve V, et al. Hand wash-
ing rituals in trauma theatre: Clean or dirty? Ann R
Coll Surg Engl 2006;88:13–15.
19. Guthery E, Seal LA, Anderson EL. Zinc pyrithione in
alcohol-based products for skin antisepsis: Persis-
tence of antimicrobial effects. Am J Infect Control
2005;33:15–22.
20. Seal LA, Rizer RL, Maas-Irslinger R. A unique water
optional healthcare personnel handwash provides an-
timicrobial persistence and residual effects while de-
creasing the need for additional products. Am J In-
fect Control 2005;33:207–216.
21. Webster J, Osborne S. Preoperative bathing or show-
ering with skin antiseptics to prevent surgical site in-
fection. Cochrane Database Syst Rev 2006;CD004985.
22. Ostrander RV, Botte MJ, Brage ME. Efficacy of surgi-
cal preparation solutions in foot and ankle surgery. J
Bone Joint Surg [Am] 2005;87:980–985.
23. Bibbo C, Patel DV, Gehrmann RM, Lin SS. Chlorhex-
idine provides superior skin decontamination in foot
and ankle surgery: A prospective randomized study.
Clin Orthop Relat Res 2005;438:204–208.
24. Ellenhorn JD, Smith DD, Schwarz RE, et al. Paint-only
is equivalent to scrub-and-paint in preoperative
preparation of abdominal surgery sites. J Am Coll
Surg 2005;201:737–741.
25. Edwards PS, Lipp A, Holmes A. Preoperative skin an-
tiseptics for preventing surgical wound infections af-
ter clean surgery. Cochrane Database Syst Rev 2004;
CD003949.
26. Kalantar-Hormozi AJ, Davami B. No need for preop-
erative antiseptics in elective outpatient plastic surgi-
cal operations: A prospective study. Plast Reconstr
Surg 2005;116:529–531.
27. Perl TM, Golub JE. New approaches to reduce Staphy-
lococcus aureus nosocomial infection rates: Treating S.
aureus nasal carriage. Ann Pharmacother 1998;32:S7–
S16.
28. Wenzel RP, Perl TM. The significance of nasal car-
riage of Staphylococcus aureus and the incidence of
DECOLONIZATION OF THE SKIN S-15
postoperative wound infection. J Hosp Infect 1995;
31:13–24.
29. Kluytmans JAJW, Mouton JW, VandenBergh MFQ, et
al. Reduction of surgical-site infections in cardiotho-
racic surgery by elimination of nasal carriage of
Staphylococcus aureus. Infect Control Hosp Epidemiol
1996;17:780–785.
30. Cimochowski GE, Harostock MD, Brown R, et al. In-
tranasal mupirocin reduces sternal wound infection
after open heart surgery in diabetics and nondiabet-
ics. Ann Thorac Surg 2001;71:1572–1579.
31. Gernaat-van der Sluis AJ, Hoogenboom-Verdegaal
AM, Edixhoven PJ, Spies-van Rooijen NH. Prophy-
lactic mupirocin could reduce orthopedic wound in-
fections: 1,044 patients treated with mupirocin com-
pared with 1,260 historical controls. Acta Orthop
Scand 1998;69:412–414.
32. Perl TM, Cullen JJ, Wenzel RP, et al.; the Mupirocin and
the Risk of Staphylococcus aureus Study Team. Intranasal
mupirocin to prevent postoperative Staphylococcus au-
reus infections. N Engl J Med 2002;346:1871–1877.
33. Suzuki Y, Kamigaki T, Fujino Y, et al. Randomized
clinical trial of preoperative intranasal mupirocin to
reduce surgical site infection after digestive surgery.
Br J Surg 2003;90:1072–1075.
34. Kluytmans JA, Mouton JW, Banden Bergh MF, et al.
Reduction of surgical site infections in cardiothoracic
surgery by elimination of nasal carriage of Staphylo-
coccus aureus. Infect Control Hosp Epidemiol 1996;17:
780–785.
35. Yano M, Kodi Y, Inoue M, et al. Preoperative in-
tranasal mupirocin ointment significantly reduces
postoperative infection with Staphylococcus aureus in
patients undergoing upper gastrointestinal surgery.
Surg Today 2000;30:16–21.
36. Wilcox MH, Hall J, Pike H, et al. Use of perioperative
mupirocin to prevent methicillin-resistant Staphylo-
coccus aureus (MRSA) orthopaedic surgical site infec-
tions. J Hospital Infection 2003;54:196–201.
37. Harbarth S, Dharan S, Liassine N, et al. Randomized,
placebo-controlled, double-blind trial to evaluate the
efficacy of mupirocin for eradicating carriage of me-
thicillin-resistant Staphylococcus aureus. Antimicrob
Agents Chemother 1999;43:1412–1416.
38. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA
Guideline for preventing nosocomial transmission of
multidrug-resistant strains of Staphylococcus aureus
and Enterococcus. Infect Control Hosp Epidemiol
2003;24:362–386.
39. Boyce JM, Opal SM, Potter-Bynoe G, Mederios AA.
Spread of methicillin-resistant Staphylococcus aureus in
a hospital and after exposure to a health-care worker
with chronic sinusitis. Clin Infect Dis 1993;17:496–504.
40. Kluytmans J, van Leeuwen W, Goessens W, et al.
Food-initiated outbreak of methicillin-resistant
Staphylococcus aureus analyzed by pheno and geno-
typing. J Clin Microbiol 1995;33:1121–1128.
41. Lessing MP, Jordens JZ, Bowlwer IC. When should
health care workers be screened for methicillin resistant
Staphylococcus aureus? J Hosp Infect 1997;35:320–321.
42. Struelens MJ, Ronveaux O, Jans B, Mertens R,
Groupement pour le Dépistage, Étude et la Préven-
tion des Infections Hospitalières. Methicillin-resistant
Staphylococcus aureus epidemiology and control in Bel-
gian hospitals, 1991 to 1995. Infect Control Hosp Epi-
demiol 1996;17:503–508.
43. Karchmer TB, Jernigan JA, Durbin BM, Simonton BM,
Farr BM. Eradication of methicillin-resistant S. aureus
(MRSA) colonization with different regimens [ab-
stract 65:42]. Presented at the Ninth Annual Meeting
of the Society for Healthcare Epidemiology of Amer-
ica; April 18–20, 1999; San Francisco, CA.
44. Kotilainen P, Routamaa M, Peltonen R, et al. Eradi-
cation of methicillin-resistant Staphylococcus aureus
from a health center ward and associated nursing
home. Arch Intern Med 2001;161:859–863.
45. Walker ES, Vasquez JE, Dula R, et al. Mupirocin-re-
sistant, methicillin-resistant Staphylococcus aureus:
Does mupirocin remain effective? Infect Control Hosp
Epidemiol 2003;24:342–346.
46. Vasquez JE, Walker ES, Franzus BW, et al. The epi-
demiology of mupirocin resistance among methi-
cillin-resistant Staphylococcus aureus at a Veterans 
Affairs hospital. Infect Control Hosp Epidemiol
2000;21:459–464.
47. Miller MA, Dascal A, Portnory J, Mendelson J. De-
velopment of mupirocin resistance among methi-
cillin-resistant Staphylococcus aureus after widespread
use of nasal mupirocin ointment. Infect Control Hosp
Epidemiol 1996;17:811–813.
48. Coia JE, Duckworth GJ, Edwards DI, et al.; Joint
Working Party of the British Society of Antimicrobial
Chemotherapy, the Hospital Infection Society, and
the Infection Control Nurses Association. Guidelines
for the control and prevention of methicillin-resistant
Staphylococcus aureus (MRSA) in healthcare facilities.
J Hospital Infection 2006;63:1–44.
49. Loeb M, Main C, Walker-Dilks C, Eady A. Antimi-
crobial drugs for treating methicillin-resistant Staphy-
lococcus aureus colonization. Cochrane Database Syst
Rev 2003;CD003340.
50. Hoffmann KK, Kittrell IP. North Carolina guidelines for
control of antibiotic-resistant organisms, specifically
methicillin-resistant Staphylococcus aureus (MRSA) and
vancomycin-resistant enterococci (VRE). 1997. Avail-
able at http://www.unc.edu/depts/spice/guide2.
html
Address reprint requests to:
Dr. Lena M. Napolitano
Department of Surgery
University of Michigan Health System
Room 1C421, University Hospital, Box 0033
1500 E. Medical Center Drive
Ann Arbor, MI 48109-0033
E-mail: lenan@umich.edu

